Prolonged-release fampridine for the treatment of myoclonus after cervical myelitis: a case report
Prolonged-release fampridine (PR-FAM), a potassium channel blocker, is approved for improving walking ability in patients with multiple sclerosis (MS). Beyond this, positive effects on other MS symptoms like fatigue, cognition, and tremor have been described. To our knowledge, a positive effect of P...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2022-03-01
|
| シリーズ: | Therapeutic Advances in Neurological Disorders |
| オンライン･アクセス: | https://doi.org/10.1177/17562864221083608 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|